Summary
59 / 100 · Bulios Score
What speaks for it
- Revenue grew by 19% a year over the last 3 years.
- It has raised its dividend 11 years in a row.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $113.9M in the last fiscal year, 17% of its market value.
What to watch
- The company made a loss over the last 12 months.
- It missed profit estimates 5 times in the last 8 quarters.
- Analysts expect revenue to fall by 8.4% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (CAD)
Diluted EPS (CAD)
- Analyst estimate
Revenue grew by 21% a year over 5 years. Over the last 3 years it grew by 19% a year. For the next fiscal year analysts expect revenue to fall by 8.4%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $341.5M.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 7.05%
- Raised in a row
- 11 years
You receive $2.12 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 2
- Sell 0
No analyst has published a price target.
60% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.